| Dr Maria L Delioukina, MD | |
|
8700 Beverly Blvd, Ac1078, West Hollywood, CA 90048-1804 | |
| (310) 423-1160 | |
| (310) 423-4646 |
| Full Name | Dr Maria L Delioukina |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 8700 Beverly Blvd, West Hollywood, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023035078 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | A65752 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Maria L Delioukina, MD 8700 Beverly Blvd, Ac1078, West Hollywood, CA 90048-1804 Ph: (310) 423-1160 | Dr Maria L Delioukina, MD 8700 Beverly Blvd, Ac1078, West Hollywood, CA 90048-1804 Ph: (310) 423-1160 |
News Archive
Allergan, Inc. today announced the U.S. Food and Drug Administration's (FDA) approval of JUVÉDERM® XC, a new formulation of the currently FDA-approved JUVÉDERM® dermal filler and the latest advancement in hyaluronic acid (HA) dermal fillers.
This post in the Malaria Policy Center blog summarizes a panel discussion, titled "Partnerships for Global Health Success: Spotlight on USAID," that took place Monday in Washington, D.C., and was sponsored by Research!America.
Plastic surgery training takes a toll on childbearing and reproductive health, including negative effects on fertility, complications during pregnancy, and breastfeeding practices, reports a study in the November issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
BioMarin Pharmaceutical Inc. today announced an update on the Phase I/II trial for BMN 110 or N-acetylgalactosamine 6-sulfatase (GALNS), intended for the treatment of the lysosomal storage disorder Mucopolysaccharidosis Type IVA (MPS IVA), or Morquio A Syndrome. Preliminary clinical data from the first 24 weeks of the study (12 weeks at 0.1mg/kg and 12 weeks at 1.0 mg/kg) have been evaluated, and BioMarin plans to announce top-line results for the full 36-week study after completion of dosing at 2.0 mg/kg in the second quarter of 2010.
A man in the U.S. infected with HIV, who knowingly exposed three women to the virus, has been sentenced to almost three years in prison.
› Verified 5 days ago
Carolyn Frances Krieg, D.O. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 8550 Santa Monica Blvd Fl 2, West Hollywood, CA 90069 Phone: 925-818-9432 | |
Dr. Jana Posalski, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 8700 Beverly Blvd, Room B-139, West Hollywood, CA 90048 Phone: 310-423-0599 Fax: 310-423-6898 | |
Veshal Malhotra, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 8700 Beverly Blvd # 220, West Hollywood, CA 90048 Phone: 310-423-5252 | |
Dr. Andrew Zadeh, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 8700 Beverly Blvd, West Hollywood, CA 90048 Phone: 310-423-5581 | |
Dr. Andrew D Ho, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 8700 Beverly Blvd, West Hollywood, CA 90048 Phone: 310-423-5161 | |
Mitali Mehta, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 8700 Beverly Blvd Ste B220, West Hollywood, CA 90048 Phone: 310-423-5252 |